BCL2 and cancer: Notably, treatment with PTX and 6-Glucan resulted in the downregulation of BCL2, Survivin, MMP7, and TGF-β in sorted MDA-MB-231 CSC mammospheres, indicating a decrease in gene expression levels associated with these cancer-related processes.